MOESM1 of Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide

Additional file 1. Supplementary tables and figures & Methodology and Material.